BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, our data in K562 and KCL22 cells show that the eight ASOs switch BIM splicing, increase total levels of E4-containing isoforms, and also resensitize BIM deletion-containing CML cells to imatinib-induced apoptotic cell death.